Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
In postmenopausal women with osteoporosis, to evaluate and compare with placebo the persistence of the effect of oral monthly ibandronate, 100 mg and 150 mg, on percent change from baseline in the biochemical marker of bone resorption, serum carboxyterminal crosslinked telopeptide of Type I collagen (CTx1), during the third month treatment (four weeks post dose compared to one week post dose).
Critère d'inclusion
- Osteoporosis in postmenopausal women